Aehr Test Systems (AEHR) Stock Price, Analysis & Valuation 2026
TradingView provides the price chart; its market feed and observation time may differ from the FMP snapshot.
Aehr Test Systems (AEHR): analysis summary
Market snapshot
FMP · 6 Nov 2026 ↗- Market cap
- $1.61B
- Analyst consensus target
- $132.50+169.5% vs quote
-19.2% session change
Financial highlights
FMP · 6 Nov 2026 ↗- Annual revenue
- $50.00M-15.2% annual growth
- Dividend yield
- 0.0%Trailing twelve months
- Next earnings
- 2027-01-08Schedule may change
- FMP DCF estimate
- $4.35-91.2% vs quote
- Fundamental score
- 4.0/10
Investment view
Aehr Test Systems exhibits a tension between its recent operating performance and its valuation. Annual revenue grew -15.2% over the comparable annual period, indicating a contraction. Despite this, the company trades at a PE ratio of 824.8x. Future disclosures need to show how the company plans to reverse its revenue trend to justify its current valuation.
Market and valuation data: Financial Modeling Prep, saved 6 Nov 2026. Price observation: 5 Nov 2026, 21:00 UTC. Editorial update: 6 Nov 2026, 03:11 UTC. Model inputs have their own retrieval time. DCF and analyst targets are separate estimates, not guaranteed outcomes. Sources and reporting periods.
Related stocks to explore alongside AEHR
Aehr Test Systems (AEHR) financial profile
The screener fundamental score for AEHR is 4.0/10, based equally on financial health, profitability and growth, plus revisions when available.
Financial health is the strongest component at 10.0/10; profitability is the weakest at 0.0/10. This describes the operating profile, not whether the share price is attractive.
Our calculation: contribution of each pillar
How Aehr Test Systems reaches 4.0/10
(10.0 + 0.0 + 0.0 + 6.1) ÷ 4 = 4.0/10. Each available component has equal weight; the display uses the same JavaScript rounding as the screener.
Swipe to see all columns
| Component | Score | Weight | Points / 10 |
|---|---|---|---|
| Financial health | 10.0/10 | 25.00% | 2.500 |
| Profitability | 0.0/10 | 25.00% | 0.000 |
| Growth | 0.0/10 | 25.00% | 0.000 |
| Revisions | 6.1/10 | 25.00% | 1.525 |
Source: saved Alert Invest stock-detail API component scores, retrieved 6 Nov 2026, 03:12 UTC. Revisions contribute when available; valuation remains separate from this average. The original component scores are retained in the saved API response; no unavailable underlying financial inputs are inferred.
The fundamental score equally averages financial health, profitability and growth, plus revisions when available. All three operating components are required. This is not an investment recommendation.
Fundamental score: 4.0/10 · input coverage: 100.0%. Retrieved 6 Nov 2026, 03:12 UTC. Screener data source. These dates may differ from the FMP market snapshot.
About Aehr Test Systems (AEHR)
Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices.
More about Aehr Test Systems
Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types.
For more complex integrated circuits like memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices, the FOX-XP and FOX-NP systems facilitate burn-in and functional testing at both the wafer and individual die/module levels. Aehr's FOX-CP system offers a compact, single-wafer solution for verifying the reliability of logic, memory, and photonic devices.
A distinguishing offering, the WaferPak Contactor, features an exclusive full-wafer probe card, accommodating wafers up to 300mm, which enables semiconductor manufacturers to conduct comprehensive wafer-level testing and burn-in on Aehr's FOX platforms. Furthermore, the DiePak Carrier provides a reusable, temporary packaging medium, empowering IC manufacturers to complete final testing and burn-in processes for bare die and modules.
Aehr Test Systems (AEHR) valuation & price targets
FMP reports an analyst target of $132.50 and a DCF estimate of $4.35, against the dated share price of $49.16. Analyst targets and DCF use different assumptions; the gap alone does not establish which is more reliable.
The DCF is a model estimate, while the analyst target is a consensus forecast. These are different measures, not guaranteed fair values.
| Measure | Value | Change vs quote | Interpretation |
|---|---|---|---|
| Analyst consensus target | $132.50 | +169.53% | External analyst target; not an intrinsic-value estimate |
| FMP DCF estimate | $4.35 | -91.16% | Provider cash-flow model; depends on its assumptions |
| P/E · TTM | 824.83x | Not applicable | Price relative to trailing earnings |
| P/B · TTM | 7.22x | Not applicable | Price relative to book equity |
| P/S · TTM | 22.01x | Not applicable | Price relative to trailing revenue |
| FCF yield · TTM | -0.42% | Not applicable | Trailing free cash flow relative to market value |
Valuation calculations and definitions
| Measure | Value | Definition |
|---|---|---|
| Analyst consensus target | $132.50 | FMP price-target-consensus; not a prediction by Alert Invest |
| Change to analyst target | +169.53% | (target / observed price − 1) × 100 |
| FMP DCF estimate | $4.35 | Third-party model estimate; assumptions require review |
| Change from price to DCF | -91.16% | (DCF / observed price − 1) × 100 |
| Price premium/discount to DCF | +1031.18% | (observed price / DCF − 1) × 100 |
Source: FMP quote, price-target-consensus and discounted-cash-flow endpoints; calculations use the dated quote. A lower earnings multiple alone does not establish undervaluation. These measures use different assumptions and are not a buy or sell recommendation.
Analyst price target range
FMP reports a low analyst target of $110.00 and a high target of $175.00. These are external price expectations, not outcome probabilities.
- Earnings or cash-flow growth falling below expectations.
- A lower valuation multiple as growth expectations or discount rates change.
- Business and regulatory risks to verify in the latest company filings.
- Consensus price target: $132.50.
- Return calculated from the same dated quote as the other cards.
- Annual EPS consensus: 0.76 for the period ending 2027-05-29 (provider reporting units).
- Earnings and cash-flow delivery exceeding the reference expectations.
- Sustained profitability while funding investment needs.
- A valuation multiple consistent with stronger expected growth.
The risk and upside checks are general valuation conditions, not the documented reasoning of individual analysts or a model deriving these targets. Rating percentages are not scenario probabilities.
Analyst consensus and rating distribution
- Analyst consensus: Buy
- 5 available ratings
The gauge shows the share of Buy and Strong Buy ratings. See the full rating distribution →
Source: FMP ratings. Analyst sentiment is not a probability of gains or an Alert Invest recommendation.
Source: FMP grades-consensus at the saved retrieval date. Rating distribution and price targets are separate datasets. The rating count is not asserted to be the number of target-price contributors.
Full rating distribution
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
AEHR key statistics & financial profile
Valuation
| Metric | Value | Signal |
|---|---|---|
| P/E · TTM | 824.8x | Reference metric |
| P/B · TTM | 7.2x | Reference metric |
| P/S · TTM | 22.0x | Reference metric |
| DCF estimate | $4.35 | Above DCF estimate |
Profitability
| Metric | Value | Signal |
|---|---|---|
| Gross margin · TTM | 40.6% | High margin |
| Net margin · TTM | 2.9% | Positive margin |
| ROE · TTM | 1.2% | Positive return |
| ROA · TTM | 0.8% | Positive return |
| ROIC · TTM | 1.9% | Positive return |
Balance sheet
| Metric | Value | Signal |
|---|---|---|
| Debt / equity · TTM | 0.0x | Low debt |
| Current ratio · TTM | 7.1x | Strong liquidity |
| Market capitalization | $1.61B | Reference metric |
Growth, cash flow & dividends
| Metric | Value | Signal |
|---|---|---|
| Annual revenue | $50,001,000.00 | Reference metric |
| Annual revenue growth | -15.2% | Declining |
| Free cash flow yield · TTM | -0.4% | Non-positive FCF |
| Dividend yield · TTM | 0.0% | Reference metric |
Data: FMP. TTM = trailing twelve months. Annual revenue period ends 2026-05-29. Sources, dates and calculations →
How to read these signals
These fixed reference bands are separate from the fundamental score and are not sector rankings or buy/sell recommendations. Bar lengths identify the reference band (85%, 55% or 50%, and 20% or 15%); they are not probabilities or additional model scores.
Debt/equity: low 0–0.5, moderate above 0.5–1.5, high above 1.5; negative equity requires review. Current ratio: strong at 2 or above, adequate at 1–2, low below 1. FCF yield: high at 5% or above, positive above zero. Gross margin: high at 40% or above, mid-range at 20–40%. Net margin: high at 20% or above. ROE and ROIC: high at 15% or above; ROA at 5% or above; otherwise positive or non-positive. Revenue growth: growing at 10% or above, modest at 0–10%, declining below zero. DCF compares the provider estimate with the dated quote. Other figures are shown without a strength judgement. These bands may be unsuitable for some industries.
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
Price trend · exponential moving averages
The daily close is below all available averages, a weak alignment across the measured horizons. This does not establish undervaluation or predict a recovery. Exponential Moving Averages (EMAs) give more weight to recent prices, making them responsive to current trends. However, EMAs are backward-looking indicators and do not predict future price movements or intrinsic value.
-24.4% · close below EMA
-35.9% · close below EMA
-32.7% · close below EMA
Blue line: daily close; dashed amber line: EMA. Source: FMP daily EMA endpoint. The latest daily observation may still be provisional during the session. Each percentage compares that session’s close with its EMA, not the separate quote above. Exponential averages give greater weight to recent prices; they are lagging indicators, not price forecasts. Method and source →
AEHR: additional technical context
Additional technical indicators
These indicators complement the fundamental assessment; they do not change the screener’s fundamental score.
The 50-session SMA averages the daily closes equally. On 2026-11-05, it stood at USD 80.50; the same-session close was 38.9% below it. This describes price positioning, not intrinsic value or a future return.
Indicator documentation →The 50-session WMA assigns greater linear weight to recent closes. On 2026-11-05, it stood at USD 74.36; the same-session close was 33.9% below it. This describes price positioning, not intrinsic value or a future return.
Indicator documentation →The 50-session DEMA combines exponential averages to reduce lag. On 2026-11-05, it stood at USD 65.62; the same-session close was 25.1% below it. This describes price positioning, not intrinsic value or a future return.
Indicator documentation →The 50-session TEMA combines multiple exponential averages to reduce lag further. On 2026-11-05, it stood at USD 55.59; the same-session close was 11.6% below it. This describes price positioning, not intrinsic value or a future return.
Indicator documentation →The 14-session RSI was 35.2 on 2026-11-05, between the conventional lower and upper thresholds. RSI compares the strength of recent price gains and losses on a zero-to-one-hundred scale; the usual reference levels are 30 and 70. An extreme reading can persist and is not by itself a reversal signal.
Indicator documentation →The 20-session standard deviation of daily prices was USD 8.90 on 2026-11-05. It describes dispersion of prices around their rolling average in price units. It is neither an annualised return-volatility percentage nor a forecast of the next price move.
Indicator documentation →Williams %R was -88.8 over 14 sessions on 2026-11-05. The oscillator locates the close within the recent high-to-low range: readings nearer zero are closer to the upper end and readings nearer minus one hundred to the lower end. This positioning does not establish that a reversal will follow.
Indicator documentation →The 14-session ADX was 31.6 on 2026-11-05. It measures the strength of a trend, not whether prices are rising or falling. Direction cannot be established from ADX alone; this reading is not a buy or sell instruction.
Indicator documentation →Source: FMP daily technical-indicator endpoints, with the observation date stated in each explanation. The latest session may be provisional. Different look-back windows measure different features of prices.
Aehr Test Systems (AEHR) earnings and forecasts
2027-01-08
Earnings and annual forecasts
| Item | Date / period | EPS |
|---|---|---|
| Next scheduled earnings in available dataset | 2027-01-08 | 0.42 |
| Latest reported earnings in available dataset | 2026-11-02 | 0.22 |
| Nearest future annual estimate | 2027-05-29 | 0.76 |
Source: FMP earnings and analyst-estimates endpoints; see source timestamps below. EPS uses provider reporting units, which may differ from the quote currency. Estimated dates and forecasts can change. An absent future event is not replaced by a past date.
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
AEHR insider filings
The 12 displayed records include 0 priced purchases and 0 priced sales. Unpriced awards and other acquisitions are excluded from these totals.
Acquisitions can include awards, gifts or other non-purchase events. Only transaction codes P and S are labelled purchases and sales; missing prices are not valued at zero. No directional investment signal is inferred.
| Date | Name | Classification | Shares | Price (USD) | Value (USD) | Filing URL |
|---|---|---|---|---|---|---|
| 2026-11-01 | SALAMONE ALBERTO | Other / unclassified | 204.00 | $54.89 | $11,197.56 | SEC filing |
| 2026-10-28 | VIJAYRAO NARSING KRISHNA | Other / unpriced transaction | 2,169.00 | $0.00 | Not available | SEC filing |
| 2026-10-28 | VIJAYRAO NARSING KRISHNA | Other / unpriced transaction | 0.00 | $0.00 | Not available | SEC filing |
| 2026-10-27 | SPORCK ALISTAIR N | Other / unclassified | 188.00 | $63.95 | $12,022.60 | SEC filing |
| 2026-10-27 | ROGERS VERNON | Other / unclassified | 197.00 | $63.95 | $12,598.15 | SEC filing |
| 2026-10-27 | RICHMOND DONALD P. II | Other / unclassified | 145.00 | $63.95 | $9,272.75 | SEC filing |
| 2026-10-27 | Erickson Gayn | Other / unclassified | 851.00 | $63.95 | $54,421.45 | SEC filing |
| 2026-10-27 | ENGINEER ADIL | Other / unclassified | 202.00 | $63.95 | $12,917.90 | SEC filing |
| 2026-10-20 | POSEDEL RHEA J | Other / unclassified | 18,000.00 | $1.77 | $31,860.00 | SEC filing |
| 2026-10-20 | POSEDEL RHEA J | Other / unclassified | 18,000.00 | $1.77 | $31,860.00 | SEC filing |
| 2026-10-12 | Siu Chris | Other / unclassified | 987.00 | $84.64 | $83,539.68 | SEC filing |
| 2026-10-12 | SPORCK ALISTAIR N | Other / unclassified | 295.00 | $84.64 | $24,968.80 | SEC filing |
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
Recent AEHR news in the available dataset
- 2026-11-05 01:21:29: Aehr Test Systems Sees Unusually Large Options Volume (NASDAQ:AEHR) (Defense World)
- 2026-11-03 11:51:08: AEHR Q1 Earnings Beat Estimates on AI Demand, Revenue Outlook Raised (Zacks Investment Research)
- 2026-11-03 06:56:01: Aehr Test Systems: 3 Key Takeaways for Long-Term Investors (The Motley Fool)
- 2026-11-03 04:33:37: Why Aehr Test Systems Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket (Benzinga)
- 2026-11-02 23:58:27: Aehr Test Systems, Inc. (AEHR) Q1 2027 Earnings Call Transcript (Seeking Alpha)
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
Sources, calculations and methodology
Alert Invest calculates the displayed valuation gaps from a dated Financial Modeling Prep quote and provider estimates. The fundamental score uses the saved screener API scores for financial health, profitability and growth, plus revisions when available, with equal weight; company research retains its own reporting period. This is a dated snapshot, not a live quote service. Missing metrics remain unavailable and do not receive a score. No AI-generated quotation or investment recommendation is added.
Financial Modeling Prep · SEC EDGAR
Data sources & dates
Financial data: Financial Modeling Prep
Price observed: 5 Nov 2026, 21:00 UTC
Annual revenue period ended: 2026-05-29
Last data refresh: 6 Nov 2026, 03:12 UTC
TTM figures cover trailing twelve months; reporting windows may differ. Scoring methodology.
The Alert Invest fundamental profile
The fundamental score equally averages financial health, profitability and growth, plus revisions when available, on a 0–10 scale to one decimal place. Component scores come directly from the same stock-detail API as the screener, with the same rounding rule. All three operating components must be available. Missing revisions are excluded rather than scored as zero.
What the radar includes
Revisions is a fourth axis for earnings-expectation context. When available, it has the same weight as each operating component in the fundamental total. Valuation is assessed separately through multiples, the provider DCF estimate and analyst targets; it is not included in this score. The separate Alert Invest trading score is also a different measure.
Value and growth research
A high fundamental score does not establish that a stock is undervalued. Compare business profitability, financial resilience and growth with the price paid; the valuation section keeps those questions separate. Published investor principles and disclosed holdings provide research leads, not extra score points or evidence of endorsement.
Source: the Alert Invest screener stock-detail API. Its component scores are supplied by the app; this page does not reconstruct missing underlying ratios. Scores reflect the saved API observation and can change when the screener refreshes. The score is a research aid, not a recommendation or a forecast of returns.
Annual revenue is labelled by statement end date. TTM metrics are provided by FMP; retrieval time is not the accounting-period end. Valuation estimates are not guarantees.
Questions about AEHR
What price is shown for AEHR?
$49.16, observed 5 Nov 2026, 21:00 UTC. This is a dated snapshot, not a live quote.
What is the analyst price target for AEHR?
FMP reports $132.50. The change from the observed quote is +169.53%. This is not a guaranteed return.
What is the P/E ratio for AEHR?
The supplied TTM P/E is 824.83x. A low or negative multiple alone is not proof of undervaluation.
When are the next AEHR earnings?
The next future date in the supplied dataset is 2027-01-08. Check company investor relations for confirmation.
What dividend information is available for AEHR?
The supplied TTM dividend yield is 0.00%. The next future payment date in the available dataset is not available. Missing data does not establish that no dividend is paid.
Sources for this section
Financial Modeling Prep · updated 6 Nov 2026, 03:11 UTC
Follow the research
Explore the portfolio and membership benefits, or follow Alert Invest on X.
For informational purposes only. Not investment advice.